Avricore Health (Avricore Health) FCF Margin % : -8.33% (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Avricore Health FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Avricore Health's Free Cash Flow for the three months ended in Dec. 2023 was $-0.08 Mil. Avricore Health's Revenue for the three months ended in Dec. 2023 was $1.01 Mil. Therefore, Avricore Health's FCF Margin % for the quarter that ended in Dec. 2023 was -8.33%.

As of today, Avricore Health's current FCF Yield % is -1.26%.

The historical rank and industry rank for Avricore Health's FCF Margin % or its related term are showing as below:

AVCRF' s FCF Margin % Range Over the Past 10 Years
Min: -25266.67 Med: -1597.93 Max: -6.78
Current: -6.78

During the past 13 years, the highest FCF Margin % of Avricore Health was -6.78%. The lowest was -25266.67%. And the median was -1597.93%.

AVCRF's FCF Margin % is ranked better than
55.86% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.255 vs AVCRF: -6.78

Avricore Health FCF Margin % Historical Data

The historical data trend for Avricore Health's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health FCF Margin % Chart

Avricore Health Annual Data

Trend

Jun14

Jun15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-2,084.00

-3,673.08

-1,117.71

-92.62

-11.09

Avricore Health Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-103.03	-46.45	-	-8.52	-8.33

Competitive Comparison of Avricore Health's FCF Margin %

For the Diagnostics & Research subindustry, Avricore Health's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avricore Health's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Avricore Health's FCF Margin % falls into.

Avricore Health FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Avricore Health's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-0.288	/	2.598
	=	-11.09 %

Avricore Health's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.084	/	1.009
	=	-8.33 %

Avricore Health FCF Margin % Related Terms

Thank you for viewing the detailed overview of Avricore Health's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Avricore Health (Avricore Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (OTCPK:AVCRF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

8VP1:Germany AVCR:Canada

Address

1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2

Website

https://www.avricorehealth.com

Avricore Health Inc is a Canada based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and sale of testing panels.